Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumihiko Kakizaki

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Gastroenterology|November 11, 2009
CDX transcription factors positively regulate expression of solute carrier family 5, member 8 in the colonic epitheliumFumihiko Kakizaki, Koji Aoki, Hiroyuki Miyoshi, et al.
Cancer Research|January 13, 2011
Suppression of colonic polyposis by homeoprotein CDX2 through its nontranscriptional function that stabilizes p27Kip1Koji Aoki, Fumihiko Kakizaki, Hiromi Sakashita, et al.
Oncotarget|May 19, 2018
An improved method for culturing patient-derived colorectal cancer spheroidsHiroyuki Miyoshi, Hisatsugu Maekawa, Fumihiko Kakizaki, et al.
Biology Open|July 12, 2015
Id2 deletion attenuates Apc-deficient ileal tumor formationKyoko Biyajima, Fumihiko Kakizaki, Xiaodong Shen, et al.
Cancer Science|August 26, 2016
Expression of metastasis suppressor gene AES driven by a Yin Yang (YY) element in a CpG island promoter and transcription factor YY2Fumihiko Kakizaki, Masahiro Sonoshita, Hiroyuki Miyoshi, et al.
Cancer Discovery|November 30, 2014
Promotion of colorectal cancer invasion and metastasis through activation of NOTCH-DAB1-ABL-RHOGEF protein TRIOMasahiro Sonoshita, Yoshiro Itatani, Fumihiko Kakizaki, et al.
Journal of Biochemistry|August 1, 2015
Characterization of Aes nuclear foci in colorectal cancer cellsYoshiro Itatani, Masahiro Sonoshita, Fumihiko Kakizaki, et al.
Molecular Cancer Therapeutics|February 13, 2023
Efficacious Combination Drug Treatment for Colorectal Cancer That Overcomes Resistance to KRAS G12C InhibitorsHiroyuki Matsubara, Hiroyuki Miyoshi, Fumihiko Kakizaki, et al.
Cancers|July 26, 2020
Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor TherapyTakehito Yamamoto, Hiroyuki Miyoshi, Fumihiko Kakizaki, et al.
Molecular Cancer Therapeutics|June 15, 2026
Involvement of tyrosine phosphatase PTPROt in acquired resistance to FGFR inhibitor therapy in colorectal cancerShoichi Kitano, Hiroyuki Miyoshi, Takehito Yamamoto, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Gastroenterology|November 11, 2009
CDX transcription factors positively regulate expression of solute carrier family 5, member 8 in the colonic epitheliumFumihiko Kakizaki, Koji Aoki, Hiroyuki Miyoshi, et al.
Cancer Research|January 13, 2011
Suppression of colonic polyposis by homeoprotein CDX2 through its nontranscriptional function that stabilizes p27Kip1Koji Aoki, Fumihiko Kakizaki, Hiromi Sakashita, et al.
Oncotarget|May 19, 2018
An improved method for culturing patient-derived colorectal cancer spheroidsHiroyuki Miyoshi, Hisatsugu Maekawa, Fumihiko Kakizaki, et al.
Biology Open|July 12, 2015
Id2 deletion attenuates Apc-deficient ileal tumor formationKyoko Biyajima, Fumihiko Kakizaki, Xiaodong Shen, et al.
Cancer Science|August 26, 2016
Expression of metastasis suppressor gene AES driven by a Yin Yang (YY) element in a CpG island promoter and transcription factor YY2Fumihiko Kakizaki, Masahiro Sonoshita, Hiroyuki Miyoshi, et al.
Cancer Discovery|November 30, 2014
Promotion of colorectal cancer invasion and metastasis through activation of NOTCH-DAB1-ABL-RHOGEF protein TRIOMasahiro Sonoshita, Yoshiro Itatani, Fumihiko Kakizaki, et al.
Journal of Biochemistry|August 1, 2015
Characterization of Aes nuclear foci in colorectal cancer cellsYoshiro Itatani, Masahiro Sonoshita, Fumihiko Kakizaki, et al.
Molecular Cancer Therapeutics|February 13, 2023
Efficacious Combination Drug Treatment for Colorectal Cancer That Overcomes Resistance to KRAS G12C InhibitorsHiroyuki Matsubara, Hiroyuki Miyoshi, Fumihiko Kakizaki, et al.
Cancers|July 26, 2020
Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor TherapyTakehito Yamamoto, Hiroyuki Miyoshi, Fumihiko Kakizaki, et al.
Molecular Cancer Therapeutics|June 15, 2026
Involvement of tyrosine phosphatase PTPROt in acquired resistance to FGFR inhibitor therapy in colorectal cancerShoichi Kitano, Hiroyuki Miyoshi, Takehito Yamamoto, et al.
Pageof 2